Following a decade of steady growth, use of bisphosphonates—medications that are effective for treating osteoporosis—declined in the United States by more than 50% from 2008 to 2012.
US experts urged regulators Wednesday to approve a second new anti-cholesterol drug, a day after recommending they bring to market the first in a new class of medications to lower the risk of heart attack.
A US advisory panel on Thursday urged regulators to approve a drug nicknamed the "female Viagra" because it could help increase women's sex drive.
A drug nicknamed the "female Viagra" because it could help increase women's sex drive, will be discussed for a third time at a meeting of an advisory committee to US regulators Thursday.
Treatment options for chronic hepatitis C, a serious and life-threatening infection, have improved substantially and several new regimens with shorter durations and improved efficacy and safety profiles are ...
A new kind of immune therapy has shown promise against the third most common blood cancer, multiple myeloma, researchers said Wednesday.
PepsiCo said Friday it was bowing to customer demand and doing away with the controversial sweetener aspartame in its diet line of cola drinks in the US.
US regulators on Wednesday approved a new kind of pacemaker-like device that aims to help people lose weight by stimulating a nerve that runs from the brain to the stomach.
US authorities have approved a test developed by Swiss pharmaceutical firm Roche that can detect both HIV and hepatitis viruses, the company said Friday.
US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.
A panel of experts convened by US health regulators failed Wednesday to recommend whether a lifetime ban should be lifted on gay men donating blood, following two days of heated deliberations.
A US ban on blood donations by gays could be eased after 31 years, depending on the decision of a Food and Drug Administration advisory committee that began two days of meetings Tuesday.
The world's top insulin maker, Novo Nordisk, reported rising quarterly profits on Thursday and said studies required to release long-acting insulin Tresiba in the US would be completed sooner than previously thought.
Ranbaxy Laboratories, India's biggest generic drugmaker by sales, reported a narrower quarterly loss on Wednesday thanks to rising sales in key markets and currency gains.
Shares in one of India's biggest drugmakers, Ranbaxy Laboratories, slid 19 percent Friday after the US Food and Drug Administration suspended imports from a fourth manufacturing plant of the firm.